<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> is a <z:e sem="disease" ids="C0559758" disease_type="Disease or Syndrome" abbrv="">multisystem disorder</z:e> of connective tissue that is inherited in an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> fashion, and results from mutation of the FBN1 gene on human chromosome 15 </plain></SENT>
<SENT sid="1" pm="."><plain>There are a number of conditions of the connective tissue with a similar phenotype that can be confused with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Modifications of the diagnostic criteria have recently been published, facilitating the differentiation of <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> from these conditions </plain></SENT>
<SENT sid="3" pm="."><plain>It is still difficult to use modern genetic testing for diagnosis because <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> can be caused by many different mutations in FBN1, a large gene with 65 coding segments, while mutations in other genes can cause overlapping phenotypes </plain></SENT>
<SENT sid="4" pm="."><plain>Several clinical trials of drug therapy, including the <z:chebi fb="0" ids="35674">antihypertensive drug</z:chebi> <z:chebi fb="0" ids="6541">losartan</z:chebi>, are in progress </plain></SENT>
</text></document>